PlainRecalls
FDA Drug Moderate Class II Terminated

Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Major Pharmaceutical 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, USA, NDC 0904-7075-61, UPC code: 309047075614

Reported: July 10, 2024 Initiated: June 18, 2024 #D-0584-2024

Product Description

Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Major Pharmaceutical 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, USA, NDC 0904-7075-61, UPC code: 309047075614

Reason for Recall

Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.

Details

Units Affected
864 cartons
Distribution
Nationwide. No foreign consignees.
Location
La Vergne, TN

Frequently Asked Questions

What product was recalled?
Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Major Pharmaceutical 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, USA, NDC 0904-7075-61, UPC code: 309047075614. Recalled by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories. Units affected: 864 cartons.
Why was this product recalled?
Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 10, 2024. Severity: Moderate. Recall number: D-0584-2024.